Valuation Ipca Laboratories Limited

Stocks

Delayed NSE India S.E. Other stock markets 10:08:03 15/07/2026 +04			5-day change	1st Jan Change
1,874.10 ^INR	+1.83%		+6.45%	+32.22%

06-26	Ipca Laboratories Limited agreed to acquire remaining 50.35% stake in Krebs Biochemicals & Industries Limited for INR 612 million.	CI
06-01	Ipca Laboratories Limited, Q4 2026 Earnings Call, Jun 01, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	270,385	205,589	313,934	381,038	406,231	466,917	-	-
Change	-	-23.96%	52.7%	21.38%	6.61%	14.94%	-	-
Enterprise Value (EV) ¹	275,070	201,870	325,349	391,231	408,673	455,093	443,257	436,086
Change	-	-26.61%	61.17%	20.25%	4.46%	11.36%	-2.6%	-1.62%
P/E	30.6x	43.6x	57.4x	51.6x	35.6x	33.5x	28.1x	24x
PBR	4.92x	2.58x	4.96x	5.48x	5.04x	4.96x	4.28x	3.6x
PEG	-	-0.9x	3.6x	1.5x	0.7x	1.5x	1.5x	1.4x
Capitalization / Revenue	4.64x	3.29x	4.07x	4.26x	4.21x	4.34x	3.89x	3.51x
EV / Revenue	4.72x	3.23x	4.22x	4.38x	4.24x	4.23x	3.69x	3.28x
EV / EBITDA	21x	21.8x	24.6x	22.7x	20.7x	19.3x	16.3x	14x
EV / EBIT	25.6x	30.3x	33.8x	29.5x	26.2x	24.1x	20.2x	17x
EV / FCF	72.9x	64.8x	60.9x	71.7x	83.5x	47.9x	40.3x	29.8x
FCF Yield	1.37%	1.54%	1.64%	1.4%	1.2%	2.09%	2.48%	3.36%
Dividend per Share ²	8	4	4	2	6	5.792	6.258	6.25
Rate of return	0.75%	0.49%	0.32%	0.13%	0.37%	0.31%	0.34%	0.34%
EPS ²	34.85	18.58	21.57	29.08	44.98	55	65.61	76.72
Distribution rate	23%	21.5%	18.5%	6.88%	13.3%	10.5%	9.54%	8.15%
Net sales ¹	58,298	62,443	77,050	89,396	96,463	107,687	120,078	132,985
EBITDA ¹	13,073	9,268	13,212	17,261	19,786	23,560	27,251	31,158
EBIT ¹	10,748	6,652	9,639	13,283	15,604	18,921	21,987	25,600
Net income ¹	8,841	4,713	5,474	7,377	11,411	14,000	16,697	19,470
Net Debt ¹	4,685	-3,720	11,415	10,193	2,442	-11,824	-23,660	-30,831
Reference price ²	1,065.75	810.35	1,237.40	1,501.90	1,601.20	1,840.40	1,840.40	1,840.40
Nbr of stocks (in thousands)	253,704	253,704	253,704	253,704	253,704	253,704	-	-
Announcement Date	24/05/22	29/05/23	29/05/24	29/05/25	29/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
IPCA LABORATORIES LIMITED	33.46x	4.23x	19.32x	0.31%	4.86B
ELI LILLY AND COMPANY	34.25x	12.25x	25.43x	0.59%	1,028B
JOHNSON & JOHNSON	27.09x	6.22x	16.9x	2.1%	611B
ABBVIE INC.	30.33x	7.27x	14.9x	2.81%	432B
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	323B
NOVARTIS AG	21.17x	5.44x	13.17x	2.9%	277B
ASTRAZENECA PLC	20.69x	4.37x	12.08x	2.02%	257B
NOVO NORDISK A/S	13.99x	5.26x	10.84x	3.55%	217B
AMGEN INC.	23.3x	6.19x	10.94x	2.84%	192B
GILEAD SCIENCES, INC.	-46.85x	5.61x	31x	2.5%	161B
Average	17.49x	6.12x	16.53x	2.27%	350.32B
Weighted average by Cap.	23.35x	7.66x	17.88x	2.04%